EQUASENS revenue for the last year amounted to 219.79 M EUR, the most of which — 162.72 M EUR — came from its highest performing source at the moment, Pharmagest, the year earlier bringing 156.30 M EUR. The greatest contribution to the revenue figure was made by France — last year it brought EQUASENS 197.16 M EUR, and the year before that — 194.49 M EUR.